Jan 12: 2 Strong Themes — Pharma / Biosimilars, Securities Brokers

January 12, 2018 · #Pharma / Biosimilars #Securities Brokers

2 strong themes — 1 recurred · 1 new. Top: Pharma / Biosimilars +15.4%.

Strong themes2 Top change+15.4% LeaderCelltrion Pharm

Average change by strong theme

Average change of member stocks, by theme · descending
Pharma / Biosimilars
+15.4%
Securities Brokers
+7.2%

Theme leaders · recent trend

The line is the trend; the end-point colour is the last trading day's direction. Stocks without enough price history show as -
ThemeLeaderChangeTrend
Pharma / BiosimilarsCelltrion Pharm+29.90%
Securities BrokersKorea Investment Holdings+8.08%

Two themes led the Jan 12 session, with Pharma / Biosimilars running hottest at an average change of 15.42%. All 5 of its stocks closed higher.

Celltrion Pharm led the group with a 29.9% gain. Celltrion Healthcare rose 15.16%, Daewoong Pharma 14.8%, Celltrion 11.24% and Hanmi Pharm 5.98%.

Securities Brokers returned after a 4-day gap, with all 3 stocks up and an average change of 7.24%. Korea Investment Holdings led at 8.08%, and KIWOOM Securities rose 7.33%.

Today’s Strong Themes at a Glance

#ThemeStatusAvg. changeUp/TotalLeader
1Pharma / Biosimilarsnew+15.4%5/5Celltrion Pharm
2Securities Brokersrecurred after 4 days+7.2%3/3Korea Investment Holdings

Theme by Theme

1. Pharma / Biosimilars (new)

StockChangeCloseLeader
Celltrion Pharm 068760+29.9%68,991★
Celltrion Healthcare 091990+15.2%128,202
Daewoong Pharma 069620+14.8%205,500
Celltrion 068270+11.2%260,888
Hanmi Pharm 128940+6.0%554,406

2. Securities Brokers (recurred after 4 days)

StockChangeCloseLeader
Korea Investment Holdings 071050+8.1%82,900★
KIWOOM Securities 039490+7.3%93,700
NH Investment & Securities 005940+6.3%16,000

Related news

Closing Thoughts

Both themes are on day 1 of their current run, so the next session will show whether the moves continue. Pharma / Biosimilars is a new entry, while Securities Brokers is a recurrence.

Trading was heaviest in Celltrion Healthcare at 13453053 shares, followed by Celltrion Pharm at 13000977. The next sessions will show whether that turnover holds up.